CareDx, Inc (CDNA)
$64.69-1.13%Close
BUYBULL · day 97
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.3B
- Beta
- 2.38
- P/E (TTM)
- 30.06
- Short % float
- 13.37%
- Days to cover
- 4.6
- SI change
- +4.6%
- 1W
- +2.62%
- 1M
- +22.89%
- vs SPY 1W
- +3.60%
- vs SPY 1M
- +21.03%
Industry peers
FMP comparable companies · ranked by market cap
- NTRABUYNatera, Inc.$56.9BBULLQ 30$394.75-0.23%
- QGENBUYQiagen N.V.$9.4BRECOVERYQ 16$45.56+0.26%
- BLLNSELLBillionToOne, Inc.$4.5BRECOVERYQ -7$97.88+3.64%
- VCYTBUYVeracyte, Inc.$3.5BBEARQ 14$43.51+0.93%
- WGSSELLGeneDx Holdings Corp.$2.0BCRISISQ -3$68.61+5.62%
- FLGTSELLFulgent Genetics, Inc.$578MRECOVERYQ 13$21.01-0.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CDNA?
- LOPJLB’s latest quantitative signal on CareDx, Inc (CDNA) is BUY in a BULL regime. Signals are updated daily.
- What market regime is CDNA in?
- CareDx, Inc (CDNA) is currently classified in the BULL HMM market regime on LOPJLB.
- What does CareDx, Inc (CDNA) do?
- CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a range of specialized diagnostic solutions for organ monitoring, including: AlloSure Kidney, AlloSure Heart, and AlloSure Lung: Advanced tests employi…